What is it about?
We compared results from nonclinical studies with ptolisant conducted in compliance of ICH S7B with the results from nonclinical studies compliant of CiPA initiative. We found the results from the two sets of studies to be consistent.
Featured Image
Read the Original
This page is a summary of: Nonclinical cardiovascular safety of pitolisant: comparing International Conference on Harmonization S7B and Comprehensive in vitro Pro‐arrhythmia Assay initiative studies, British Journal of Pharmacology, October 2017, Wiley,
DOI: 10.1111/bph.14047.
You can read the full text:
Contributors
The following have contributed to this page
